fashion -WSS

fashion

author：entertainment 2025-08-25 07:30:13 - browse：29

A collage illustration with a patient in the center with a hand to the left administering treatment and a doctor in the background. -- health tech coverage from STAT — Katy Lemay for STAT

The makers of minimally invasive surgical devices seemed poised to capture a wide swath of the obesity treatment market. Patients needed an option that lay between the two treatment extremes: cutting open the abdomen to perform permanent bariatric surgery, or changing your diet or exercise routine.

Then, a new class of weight loss medications that successfully mimic the feeling of fullness hit the market, and the landscape changed.

“It turns out that what came along — before those endoscopic devices have really matured — is these new drugs,” said Lee Kaplan, director of Massachusetts General’s obesity institute. Since the Food and Drug Administration approved Novo Nordisk’s Wegovy in 2021, it and similar drugs that followed have swiftly captured the public’s interest — and are on their way to generating billions of dollars in sales.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Eyeing GLP

hotspot

Wikipedia

WSS

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Judge rejects Trump's request to move Stormy Daniels hush

Stanford president faces new allegations over 1999 paper

Cue Health, Covid

UnitedHealth argues against case alleging wrongful AI care denials

Mass General totes up its waste in a move to tackle climate change

knowledge

fashion

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

ASCO eve: Let’s set the table for this year's meeting

Activists slam private health insurers over coverage restrictions

Listen: More tumult at BIO & coercive care for sickle cell patients

Cancer drug shortages should be causing more outrage

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

Psychedelics group wrestles with new pharma identity

Hospitals struggle to profit from CAR

George Santos makes 1st court appearance after pleading not guilty to 13 counts

At flashy new research hub, AstraZeneca lays out ambitious growth goals

focus

Tocagen's brain cancer gene therapy trial continues. Investors worry

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Vir antibody drug aimed at influenza A fails in clinical trial

Cue Health, Covid

Making the case for fair compensation in clinical trials

Ending racial health disparities hinges on penalties, political will

leisure time

hotspot

Wikipedia

Wikipedia